Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10020921HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10020920HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10014897HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10014898HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10020940HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10031645HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10031646HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10033377HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS10042368HBVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TVIS30072819HIVENSG00000101958.14protein_codingGLRA2NoNo2742P23416
TCGA Plot Options
Drug Information
GeneGLRA2
DrugBank IDDB01956
Drug NameTaurine
Target IDBE0000745
UniProt IDP23416
Regulation Typeagonist
PubMed IDs
Citations
GroupsApproved; Nutraceutical
Direct ClassificationOrganosulfonic acids
SMILESNCCS(O)(=O)=O
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA451590
ChEMBLCHEMBL239243